DVA

DaVita Inc. · NYSE

Sector Health Services
Industry Medical/Nursing Services
Website davita.com
Employees(FY) 70000
ISIN US23918K1088

Performance

+4.19%

+18.18%

+25.35%

+29.71%

+18.37%

YTD

+63.66%

Profile

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

Advanced Technical Analysis

Technical Analysis of DVA 2025-02-03

The stock exhibits a strong bullish sentiment with a Moving Average Score of 90 and a Technical Score of 89, indicating robust upward momentum. However, the Oscillators Score of 50 suggests a neutral stance, implying that while the overall trend is positive, there may be some consolidation or indecision in the short term.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of DVA

Stock Rank

Recent News & Updates

2025-02-03 11:38
GEHC Stock May Gain on FDA's Nod for the Updated Voluson Expert Series(Zacks)
2025-02-03 08:35
For Improving Transplant Access, Collaboration Holds the Key(ACCESS Newswire)
2025-02-02 10:00
2 Warren Buffett Stocks to Buy Without Hesitation If You Have $1,000 to Invest Right Now(Motley Fool)
2025-02-02 04:05
3 No-Brainer Warren Buffett Stocks to Buy Right Now(Motley Fool)
2025-02-01 07:24
DaVita (NYSE:DVA) jumps 3.5% this week, though earnings growth is still tracking behind five-year shareholder returns(Simply Wall St.)
2025-01-31 11:16
Surmodics Stock Down Despite Q1 Earnings Beat, Gross Margin Up(Zacks)
2025-01-31 09:07
ANGO Stock Looks Promising on New Ischemia Study for Auryon System(Zacks)
2025-01-31 08:45
Heroes in Scrubs: Celebrating the Importance of Nurses in Kidney Care(ACCESS Newswire)
2025-01-31 07:46
4 Stocks Trading Near 52-Week High With Room to Rise Further(Zacks)
2025-01-31 02:35
Is DaVita Inc. (DVA) Among Warren Buffett’s Longest-Held Stocks?(Insider Monkey)
2025-01-30 22:55
DaVita Inc. Schedules 4th Quarter 2024 Investor Conference Call(Prnewswire)
2025-01-30 11:55
DaVita Inc. Schedules 4th Quarter 2024 Investor Conference Call(PR Newswire)
2025-01-30 11:09
CAH Q2 Earnings and Sales Beat Estimates, 2025 EPS View Raised(Zacks)
2025-01-30 10:51
Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now(Zacks)
2025-01-29 21:36
DaVita Inc. (DVA): Enhancing Kidney Care Through Advanced AI Models(Insider Monkey)
2025-01-29 18:00
DaVita HealthCare (DVA) Ascends While Market Falls: Some Facts to Note(Zacks)
2025-01-29 12:00
DaVita HealthCare (DVA) Upgraded to Strong Buy: Here's Why(Zacks)
2025-01-29 09:40
Is CareDx (CDNA) Outperforming Other Medical Stocks This Year?(Zacks)
2025-01-28 19:00
DVA: Raising target price to $182.00(Argus Research)
2025-01-28 12:04
Bernstein Adjusts Price Target on DaVita to $184 From $161, Maintains Market Perform Rating(MT Newswires)
2025-01-28 10:18
Here's Why you Should Retain Veeva Systems Stock in Your Portfolio Now(Zacks)
2025-01-28 09:25
Zacks Investment Ideas feature highlights: Nvidia, Vertiv, Vistra and DaVita(Zacks)
2025-01-27 16:19
Top Stock Picks for Week of January 27, 2025(Zacks)
2025-01-27 13:16
Sell Nvidia, Buy This Stock(Zacks)
2025-01-27 11:35
VEEV Stock Falls Despite Tie-Up to Streamline Customers' Operations(Zacks)
2025-01-23 18:15
DaVita HealthCare (DVA) Exceeds Market Returns: Some Facts to Consider(Zacks)
2025-01-21 19:00
DVA: Raising target price to $178.00(Argus Research)
2025-01-20 11:07
Masimo Stock Gains Following Solid Preliminary Q4 Revenues(Zacks)
2025-01-20 09:40
Is DaVita (DVA) Stock Undervalued Right Now?(Zacks)
2025-01-17 18:00
DaVita HealthCare (DVA) Gains But Lags Market: What You Should Know(Zacks)

Page 1 of 10

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.